Antares Pharma, Inc. (ATRS)

Other Income/Expenses (Net)

-$174.00K

Quarterly · Period ending: · USD

ATRS logo

ATRS Other Income/Expenses (Net)

Latest reported-$174.00K
ATRS Quarterly Other Income/Expenses (Net) ($0.00 → -$174.00K)
High-resolution chart · PNG

ATRS other income/expenses (net) history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Antares Pharma, Inc. Other Income/Expenses (Net) — Quarterly (USD)
Period endingOther Income/Expenses (Net) (USD)
-174,000
0
-744,000
-1,224,000
-1,008,000
-992,000
-854,000
-867,000
-985,000
-872,000
-953,000
-637,000
-557,000
-654,000
-577,000
-609,000
-574,000
305,126
-506,711
-120,341
29,926
-180,657
15,462
-9,215
52,066
39,499
29,526
-45,181
-45,711
-7,750
-12,837
-6,572
13,739
12,063
9,223
27,414
-5,159
32,944
-15,025
-16,535
22,665
-46,275
-32,758
42,298
30,897
-81,272
22,069
-7,782
-24,072
75,302
-12,334
-33,518
-196,965
15,826
-18,106
10,266
-31,856
-12,634
-2,643
-20,652
2,899
-120,992
-33,198
-174
-18,757
9,976
-14,651
-3,904
5,493
28,151
-6,113
-9,610
12,590
-136,316
-20,660,393
-1,689,097
-749,549
636,335
-1,901,417
-55,158
12,691
4,780
2,924
49,580
16,180
0
0
0
0
0
0
0
0
0
100,000
100,000
100,000
0
100,000
100,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.